Shenzhen New Industries Biomedical Engineering Co Ltd SZSE:300832:
Q3 NET PROFIT DOWN 9.7% Y/Y
New Industries Biomedical Q3 Net Profit Down 9.7% Y/Y
Shenzhen New Industries Biomedical Engineering Co. Ltd. on 6ix
Story so far
Earlier from Shenzhen New Industries Biomedical Engineering
- Shenzhen New Industries Biomedical Engineering Co: H1 2025 revenue fell 1.18% to ¥2.18B, net profit down 14.62%, overseas sales up 19.57%
- Shenzhen New Industries Biomedical Engineering Co: 2024 revenue up 15.41%, net profit up 10.57%, strong global growth and high dividend
- Shenzhen New Industries Biomedical Engineering Co: Double-digit revenue and profit growth, led by robust overseas expansion and innovation
- Shenzhen New Industries Biomedical Engineering Co: Q3 revenue and profit rose double digits year-over-year, driven by strong product and market growth
- Shenzhen New Industries Biomedical Engineering Co: Net profit surged 20.42% year-over-year on robust sales and margin gains
Later from Shenzhen New Industries Biomedical Engineering
- Shenzhen New Industries Biomedical Engineering Co: Revenue up 3.28% in Q3 2025, but net profit down 9.72% as domestic sales declined
- Shenzhen New Industries Biomedical Engineering Q1 Net Profit Up 1% Y/Y
- 2025 revenue rose 0.91% to ¥4.58B, with net profit down 11.39% amid strong overseas growth
- Shenzhen New Industries Biomedical Engineering's Actual Controller Under Detention
Follow Shenzhen New Industries Biomedical Engineering into a list and get an email when it puts out news.
Follow Shenzhen New Industries Biomedical Engineering